Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 413,259 $ 286,250
Equity method investments 1,468,282 1,279,651
Loans 1,351,000  
Real estate 356,861 359,176
Investments 17,637 55,377
Securitization assets 203,625 164,342
Other assets 130,046 100,364
Total Assets 3,940,863 3,459,067
Liabilities:    
Accounts payable, accrued expenses and other 77,395 59,944
Credit facilities 25,483 22,591
Non-recourse debt (secured by assets of $574 million and $723 million, respectively) 438,051 592,547
Senior unsecured notes 1,771,264 1,283,335
Convertible notes 155,285 290,501
Total Liabilities 2,467,478 2,248,918
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 84,275,179 and 76,457,415 shares issued and outstanding, respectively 843 765
Additional paid in capital 1,671,747 1,394,009
Accumulated deficit (225,933) (204,112)
Accumulated other comprehensive income (loss) 7,746 12,634
Non-controlling interest 18,982 6,853
Total Stockholders’ Equity 1,473,385 1,210,149
Total Liabilities and Stockholders’ Equity 3,940,863 3,459,067
Commercial receivables    
Assets    
Loans 1,224,741 965,452
Government receivables    
Assets    
Loans $ 126,412 $ 248,455